(Q36752195)

16 August 2017

1 reference

title

Dendritic cell-based immunotherapy of malignant melanoma: success and limitations (English)

1 reference

16 August 2017

1 reference

1 reference

4

1 reference

16 August 2017

Andrea Tuettenberg

1

1 reference

16 August 2017

Edgar Schmitt

series ordinal

2

1 reference

16 August 2017

Jürgen Knop

series ordinal

3

1 reference

16 August 2017

publication date

1 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

5

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

190-196

1 reference

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Regulation of tumour immunity by CD25+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Immature, but not inactive: the tolerogenic function of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Tumor-driven evolution of immunosuppressive networks during malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

The immunobiology of the TLR9 subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

Toll-like receptor 2 controls expansion and function of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06179.X

10.1111/J.1610-0387.2007.06179.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference